knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 10:33:15 - browse：42816

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： First Opinion Podcast: How to protect health care in times of war

focus

WSS

The pink breast cancer awareness ribbon needs a redesign

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Senate panel to vote on hospitals, PBMs, prisoner care

Senate panel to vote on hospitals, PBMs, prisoner care

Biden's order seeks to regulate AI risk without stifling innovation

Testing for cancer recurrence creates a new limbo for patients

focus

knowledge

knowledge

Guidelines to prevent youth baseball injuries need more muscle

FDA has safety concerns on CRISPR

Medical leaders decry Supreme Court decision on affirmative action

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Drug repurposing or repositioning? The language matters

CDC recommends rationing of RSV shot due to shortages

Medical records are filled with copy

Diversifying clinical trials isn't enough to close racial gaps: study

Wildfire smoke exposes gaps in outdoor worker protections

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

knowledge

Recent heat wave in the Mediterranean caused by climate change: Study

Physician subsidies by hospitals soar in wake of No Surprises Act

Biden's order seeks to regulate AI risk without stifling innovation

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Pandemic and All Hazards Preparedness Act needs lean update

Judge agrees to delay next hearing in Trump classified documents case

entertainment

focus

focus

hotspot